MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
366.89%
Quick Ratio
366.89%
Cash Ratio
240.63%
Debt to Asset Ratio
26.86%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Marketable securities
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses
    • Others

Balance Sheets
2026-03-31
Cash and cash equivalents
30,789
Marketable securities
14,614
Prepaid expenses and other current assets
1,540
Total current assets
46,943
Property and equipment, net
427
Right-of-use asset - operating lease
801
Other assets
393
Total assets
48,564
Accounts payable
1,535
Accrued expenses
8,755
Notes payable
96
Deferred revenue - current portion
1,710
Less operating lease liabilities - current portion
699
Total current liabilities
12,795
Deferred revenue - non-current portion
0
Operating lease liabilities - non-current portion
249
Total liabilities
13,044
Common stock, 0.001 par value 325,000,000 shares authorized at march31, 2026 and march31, 2025 39,624,839 and 29,001,481 shares issued at march31, 2026 and march31, 2025, respectively
40
Additional paid-in capital
516,767
Treasury stock, at cost, 4,522 shares of common stock held at march31, 2026 and march31, 2025
3,968
Accumulated other comprehensive gain (loss)
-2
Accumulated deficit
-477,317
Total stockholders equity
35,520
Total liabilities and stockholders equity
48,564
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$30,789K Marketable securities$14,614K Prepaid expenses andother current assets$1,540K Total current assets$46,943K Right-of-use asset -operating lease$801K Property and equipment,net$427K Other assets$393K Total assets$48,564K Total liabilities andstockholders equity$48,564K Total stockholdersequity$35,520K Total liabilities$13,044K Accumulated deficit-$477,317K Treasury stock, at cost,4,522 shares of common...$3,968K Accumulated othercomprehensive gain (loss)-$2K Additional paid-in capital$516,767K Total currentliabilities$12,795K Operating leaseliabilities - non-current...$249K Common stock, 0.001 parvalue 325,000,000...$40K Accrued expenses$8,755K Deferred revenue -current portion$1,710K Accounts payable$1,535K Less operating leaseliabilities - current...$699K Notes payable$96K

Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics, Inc. (VTGN)